Status | Study |
Active, not recruiting |
Study Name: A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions Condition: Hereditary Angioedema Date: 2017-04-24 Interventions: Drug: BCX7353 Day 11-18 for Co |
Recruiting |
Study Name: Biomarker for Hereditary Angioedema Disease Type 1 Condition: Hereditary AngioEdema Angioedema, Heredit Date: 2017-01-18 |
Recruiting |
Study Name: The Role of the Coagulation Pathways in Recurrent Angioedema Condition: Chronic Spotaneous Urticaria, Idiopathic Non Histaminergic Angioderma, Hereditary Angioedema With C1 Inhibitor Deficiency Date: 2016-09-02 Interventions: Other: BLOOD TEST |
Recruiting |
Study Name: Efficacy and Safety of BCX7353 to Prevent Angioedema Attacks in Subjects With Hereditary Angioedema Condition: Hereditary Angioedema (HAE) Date: 2016-08-10 Interventions: Drug: BCX7353 Plasma kallikrei |
Active, not recruiting |
Study Name: Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE) Condition: Hereditary Angioedema (HAE) Date: 2016-08-09 Interventions: Drug: CINRYZE 500 U IV infusio |
Recruiting |
Study Name: Determination of Specific Biomarkers of Acute Attack of Angioedema Within Pediatric Population Condition: Hereditary Angioedema Healthy Volunteers Date: 2016-07-18 Interventions: Other: blood sample |
Completed |
Study Name: An Open-label Drug-Drug Interaction Study to Evaluate the Effect of BCX7353 on Cytochrome P450 Enzyme Activity Using Probe Substrates Condition: Hereditary Angioedema Date: 2016-06-28 Interventions: Drug: BCX7353 and probes |
Active, not recruiting |
Study Name: Long-term Safety and Efficacy Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE Condition: Hereditary Angioedema Date: 2016-04-08 Interventions: Drug: DX-2930 Rollover subject |
Terminated |
Study Name: Open-label, Long-term Safety Study of Avoralstat in Subjects With Hereditary Angioedema Condition: Hereditary Angioedema HAE Date: 2016-01-20 Interventions: Drug: avoralstat Other Name: BCX4161 |
Completed |
Study Name: Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Recombinant Human C1 Esterase Inhibitor in Healthy Adult Subjects Condition: Hereditary Angioedema (HAE) Date: 2015-12-21 Interventions: Drug: Recombinant human C1 esterase inhibitor |